Global viewpoints: updates on prostate cancer in Sub-Saharan Africa.
Sub-Saharan
cancer
diagnosis
prostate
surgery
Journal
BJU international
ISSN: 1464-410X
Titre abrégé: BJU Int
Pays: England
ID NLM: 100886721
Informations de publication
Date de publication:
13 Sep 2023
13 Sep 2023
Historique:
pubmed:
13
9
2023
medline:
13
9
2023
entrez:
13
9
2023
Statut:
aheadofprint
Résumé
Prostate cancer (PCa) is a major health concern in Sub-Saharan Africa (SSA), with high incidence and mortality rates. However, the widely used prostate-specific antigen (PSA) screening is not readily available or affordable in SSA. Alternative screening strategies, such as risk stratification approaches and cost-effective PSA tests, are being explored to target high-risk individuals and improve access to screening. Diagnosis of PCa in SSA is challenging due to the lack of access to diagnostic tools and limited healthcare resources. Clinical evaluation and digital rectal examination are commonly used, but PSA testing, magnetic resonance imaging, and biopsy are often limited. As a result, many men in SSA are diagnosed at advanced stages of the disease. Treatment options for PCa in SSA are often limited by a lack of resources and trained healthcare providers. Surgery, radiation therapy, and androgen-deprivation therapy are available but may be inaccessible to many patients. Cultural beliefs and stigma surrounding PCa further impact treatment decisions. Improved patient and community awareness, electronic medical records, and communication between patients and healthcare professionals can enhance evidence-based decision-making and advocate for policy changes. Understanding the genetic determinants and implementing comprehensive strategies can lead to improved outcomes and better control of PCa in SSA.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2023 BJU International.
Références
Sung H, Ferlay J, Siegel RL et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021; 71: 209-249
Adeloye D, David RA, Aderemi AV et al. An estimate of the incidence of prostate cancer in Africa: a systematic review and meta-analysis. PLoS One 2016; 11: e0153496
Rebbeck TR, Devesa SS, Chang BL et al. Global patterns of prostate cancer incidence, aggressiveness, and mortality in men of African descent. Prostate Cancer 2013; 2013: 560857
McGinley K, Tay K, Moul J. Prostate cancer in men of African origin. Nat Rev Urol 2016; 13: 99-107
Ferlay J, Ervik M, Lam F et al. Global Cancer Observatory: Cancer Today. Lyon: International Agency for Research on Cancer, 2021
Morhason-Bello IO, Odedina F, Rebbeck TR et al. Challenges and opportunities in cancer control in Africa: a perspective from the African organisation for research and training in cancer. Lancet Oncol 2013; 14: e142-e151
Bray F, Jemal A, Grey N, Ferlay J, Forman D. Global cancer transitions according to the human development index (2008-2030): a population-based study. Lancet Oncol 2012; 13: 790-801
Center MM, Jemal A, Lortet-Tieulent J et al. International variation in prostate cancer incidence and mortality rates. Eur Urol 2012; 61: 1079-1092
Ha Chung B, Horie S, Chiong E. The incidence, mortality, and risk factors of prostate cancer in Asian men. Prostate Int 2019; 7: 1-8
Bunker CH, Patrick AL, Konety BR et al. High prevalence of screening-detected prostate cancer among Afro-Caribbeans: the Tobago Prostate Cancer Survey. Cancer Epidemiol Biomarkers Prev 2002; 11: 726-729
Odedina FT, Akinremi TO, Chinegwundoh F et al. Prostate cancer disparities in black men of African descent: a comparative literature review of prostate cancer burden among black men in the United States, Caribbean, United Kingdom, and West Africa. Infect Agent Cancer 2009; 4(Suppl 1): S2
Moyer VA, U.S. Preventive Services Task Force. Screening for prostate cancer: U.S. preventive services task force recommendation statement. Ann Intern Med 2012; 157: 120-134
Makau-Barasa LK, Manirakiza A, Carvalho AL, Rebbeck TR. Prostate cancer screening, diagnostic, treatment procedures and costs in Sub-Saharan Africa: a situational analysis. Cancer Control 2022; 29: 10732748221084932
Bosland MC, Shittu OB, Ikpi EE, Akinloye O. Potential new approaches for prostate cancer management in resource-limited countries in Africa. Ann Glob Health 2023; 89: 14
Preston MA, Gerke T, Carlsson SV et al. Baseline prostate-specific antigen level in midlife and aggressive prostate cancer in black men. Eur Urol 2019; 75: 399-407
Kingham TP, Alatise OI, Vanderpuye V et al. Treatment of cancer in Sub-Saharan Africa. Lancet Oncol 2013; 14: e158-e167
Seraphin TP, Joko-Fru WY, Hämmerl L et al. Presentation, patterns of care, and outcomes of patients with prostate cancer in Sub-Saharan Africa: a population-based registry study. Cancer 2021; 127: 4221-4232
Cassell A, Yunusa B, Jalloh M et al. A review of localized prostate cancer: an African perspective. World J Oncol 2019; 10: 162-168
Jalloh M, Zhu D, Agalliu I et al. MP67-18 clinical characteristics of prostate cancer patients in west and South Africa in the Men of African Descent and Carcinoma of the Prostate (MADCaP) consortium study. J Urol 2021; 206(Suppl 3): e516-e517
Chu LW, Ritchey J, Devesa SS, Quraishi SM, Zhang H, Hsing AW. Prostate cancer incidence rates in Africa. Prostate Cancer 2011; 2011: 947870
Gueye SM, Zeigler-Johnson CM, Friebel T et al. Clinical characteristics of prostate cancer in African Americans, American whites, and Senegalese men. Urology 2003; 61: 987-992
Ahmed RO, Sewram V, Oyesegun AR, Ayele B, van Wyk A, Fernandez P. A comparison of clinicopathologic features of prostate cancer between Nigerian and South African black men. Afr J Urol 2022; 28: 6
Cassell A, Yunusa B, Jalloh M et al. Management of advanced and metastatic prostate cancer: a need for a Sub-Saharan guideline. J Oncol 2019; 2019: 1785428
Rawla P. Epidemiology of prostate cancer. World J Oncol 2019; 10: 63-89
Rutherford ME, Mulholland K, Hill PC. How access to health care relates to under-five mortality in Sub-Saharan Africa: systematic review. Trop Med Int Health 2010; 15: 508-519
Jalloh M, Niang L, Ndoye M, Labou I, Gueye SM. Prostate cancer in Sub Saharan Africa. J Nephrol Urol Res 2013; 1: 15-20
Niang L, Jalloh M, Labou I et al. Radical prostatectomy: short term evaluation of 18 cases. J Afr Cancer 2009; 1: 176-179
Kyei MY, Adusei B, Klufio GO, Mensah JE, Gepi-Attee S, Asante E. Treatment of localized prostate cancer and use of nomograms among urologists in the West Africa sub-region. Pan Afr Med J 2020; 36: 251
Kyei MY, Mensah EJ, Gepi-Attee S et al. Outcomes after radical prostatectomy in Ghanaians: a surgeon's early experience. ISRN Urol 2013; 2013: 832496
NCCN harmonized guidelines™ for Sub-Saharan Africa. Prostate cancer, version 2.2017. Available at: www.nccn.org/patients. Accessed November 2017
Pelicci PG. IEO scientific report 2013. Ongoing research 2014. Surg Oncol 2012; 19: 3771-3776
Osaghae SO. Update of guidelines for management of prostate cancer in West Africa 2019: consensus working document. West Afr J Med 2020; 37: 159-172
Alfano CM, Mayer DK, Bhatia S et al. Implementing personalized pathways for cancer follow-up care in the United States: proceedings from an American Cancer Society-American Society of Clinical Oncology summit. CA Cancer J Clin 2019; 69: 234-247
Odekunle FF, Odekunle RO, Shankar S. Why Sub-Saharan Africa lags in electronic health record adoption and possible strategies to increase its adoption in this region. Int J Health Sci 2017; 11: 59-64
Benedict MO, Steinberg WJ, Claassen FM, Mofolo N. Enhancing public awareness and practice of prostate cancer screening among African men: a scoping review. S Afr Fam Pract 2023; 65: e1-e11
Andrews C, Fortier B, Hayward A et al. Development, evaluation, and implementation of a pan-African cancer research network: men of African descent and carcinoma of the prostate. J Glob Oncol 2018; 4: 1-14
Odiaka E, Lounsbury DW, Jalloh M et al. Effective project management of a pan-African cancer research network: men of African descent and carcinoma of the prostate (MADCaP). J Glob Oncol 2018; 4: 1-12
Zeigler-Johnson CM, Walker AH, Mancke B et al. Ethnic differences in the frequency of prostate cancer susceptibility alleles at SRD5A2 and CYP3A4. Hum Hered 2002; 54: 13-21
Fernandez P, Zeigler-Johnson CM, Spangler E et al. Androgen metabolism gene polymorphisms, associations with prostate cancer risk and pathological characteristics: a comparative analysis between South African and Senegalese men. Prostate Cancer 2012; 2012: 798634
Chen F, Darst BF, Madduri RK et al. Validation of a multi-ancestry polygenic risk score and age-specific risks of prostate cancer: a meta-analysis within diverse populations. Elife 2022; 11: e78304
Kim MS, Naidoo D, Hazra U et al. Testing the generalizability of ancestry-specific polygenic risk scores to predict prostate cancer in Sub-Saharan Africa. Genome Biol 2022; 23: 194
Wang Y, Ray AM, Johnson EK, Zuhlke KA, Cooney KA, Lange EM. Evidence for an association between prostate cancer and chromosome 8q24 and 10q11 genetic variants in African American men: the Flint Men's Health Study. Prostate 2011; 71: 225-231
Darst BF, Wan P, Sheng X et al. A germline variant at 8q24 contributes to familial clustering of prostate cancer in men of African ancestry. Eur Urol 2020; 78: 316-320